Talati A, Fyer A J, Weissman M M
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Mol Psychiatry. 2008 Feb;13(2):122-30. doi: 10.1038/sj.mp.4002114. Epub 2007 Oct 16.
The National Institute of Mental Health (NIMH) has supported the collection of DNA samples on over 4000 subjects for use primarily as controls in psychiatric genetic studies. These subjects, though screened online, were not directly interviewed or assessed on family history. We compared this sample to one that was directly interviewed using structured diagnostic assessments on comparable measures of neuroticism and extraversion. The screened sample completed an online self-report based on the Composite International Diagnostic Instrument Short-Form (CIDI-SF). The interviewed sample was assessed by clinically trained personnel using the Schedule for Affective Disorders and Schizophrenia (SADS-LA-IV) and Family History Screen; final diagnoses were made blind to trait scores by a clinician using the best-estimate procedure. Neuroticism and extraversion were assessed on the NEO five-factor inventory (NEO-FFI) and the revised Eysenck Personality Questionnaire short form (EPQ-R). We found that subjects in the NIMH-screened sample who did not report any psychiatric symptoms on the self-report were indistinguishable from interviewed diagnosis free and family history negative controls on neuroticism and extraversion. Subjects in the screened sample who screened positive for anxiety disorders, however, deviated significantly on these measures both from the screened subjects with no self-reported symptoms, as well as from subjects in the interviewed sample diagnosed with comparable disorders. These findings suggest that control groups generated from the NIMH sample should ideally be restricted to subjects free of any self-reported symptoms, regardless of the disorder being addressed, in order to maximize their reflection of diagnosis-free populations.
美国国立精神卫生研究所(NIMH)资助采集了4000多名受试者的DNA样本,主要用作精神疾病遗传学研究的对照。这些受试者虽然是通过网络筛选的,但未直接接受访谈或进行家族史评估。我们将这个样本与另一个通过结构化诊断评估直接访谈的样本进行了比较,该评估涉及神经质和外向性的可比测量。筛选样本基于综合国际诊断工具简表(CIDI-SF)完成了一份在线自我报告。访谈样本由经过临床培训的人员使用情感障碍和精神分裂症量表(SADS-LA-IV)和家族史筛查进行评估;最终诊断由一名临床医生采用最佳估计程序在不了解特质分数的情况下做出。神经质和外向性通过NEO五因素问卷(NEO-FFI)和修订版艾森克人格问卷简表(EPQ-R)进行评估。我们发现,在自我报告中未报告任何精神症状的NIMH筛选样本中的受试者,在神经质和外向性方面与接受访谈的无诊断且家族史为阴性的对照组没有区别。然而,在筛选样本中被筛查出焦虑症呈阳性的受试者,在这些测量上与没有自我报告症状的筛选受试者以及在接受访谈样本中被诊断患有类似疾病的受试者均有显著差异。这些发现表明,理想情况下,从NIMH样本中生成的对照组应仅限于没有任何自我报告症状的受试者,无论所研究的疾病是什么,以便最大程度地反映无诊断人群。